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THE title Morbus Maculosis Werlhofii for the severe form of purpura haemorrhagica
is derived from the fact that the first clear and accurate clinical account of this
condition was made by Werlhof in 1775. However, over two centuries earlier, a
Portuguese called Amatus Lusitanus described in one of his works, under the title
of Morbus Pulicaris Absque Febre, the case of a boy with undoubted acute
haemorrhagic purpura who had a spontaneous recovery. Indeed, little can be
added to-day to these earlier clinical descriptions which are full of the fruits of
keen observation and reflect the scholarship of their age.
The disease is characterised by the presence of petechial hoemorrhages in the
skin-compared by one earlier worker to "flea bitings." These are more commonly
seen in the limbs but may also occur on the trunk. These minute haemorrhages
may spread to produce purpuric spots or coalesce to form extensive superficial
ecchymoses. Associated lesions are commonly seen in the buccal mucosa where
they assume the characters of blood filled blisters. These manifestations are
associated with free bleeding from mucous surfaces with epistaxis, hoematuria,
haematemesis or persistent oozing from the gums. In women profuse uterine
bleeding is not uncommon and may be the presenting sign and reason for the
patient's hospitalisation, as it has been in two of our cases.
It was not until late in the nineteenth century that Bizzozero (1882) noted the
relationship of blood platelets to clot formation and this was quickly followed by
the observation in some cases of purpura of a diminished number of circulating
blood platelets. Thus, the understanding of the function of blood platelets preceded
any knowledge as to their origin, which was the subject of considerable dispute
until Wright (1910) clearly demonstrated platelets budding off from the
megakaryocytes of the bone marrow.
Further study of the relationship of circulating blood platelets to the presence of
clinical purpura received intensive study which revealed that there were two major
kinds of purpura. In the first of these the number of circulating blood platelets
is normal. This is called non-thrombocytopenic purpura and in this type the
bleeding is almost certainly due to a disturbance of the walls of blood vessels.
In the second type the number of circulating blood platelets is reduced. This is
called thrombocytopenic purpura and in this type the bleeding is clearly related to
the diminished number of circulating blood platelets although, an associated
vascular defect cannot be entirely excluded.
113Purpura with a decrease in the circulating blood platelets can be produced in
a number of ways. It is often secondary to other diseases, particularly those
diseases of the haemopoietic system, which are associated with marrow replace-
ment and consequent reduction in the number or interference with the function
of the parent megakaryocytes. Thrombocytopenic purpura may also be caused
by the damaging effect of hamatotoxic drugs on the megakaryocytes of the
bone marrow. Because of the oetiology, this type is known as 'secondary
thrombocytopenic purpura.' In other cases, however, no known cause for the
thrombocytopenia can be discovered and these are classified as 'primary' or
'idiopathic thrombocytopenic purpura.'
IDIOPATHIC THROMBOCYTOPENIC PURPURA.
The mechanism for the production of thrombocytopenia in this type of purpura
has been the subject of controversy. The theories can be broadly classified into
those which envisage increased peripheral destruction or utilisation of platelets
and those which regard the reduced platelet count in the peripheral blood as being
the result of diminished platelet formation in the bone marrow. Kaznelson (1916)
postulated an accelerated phagocytosis of platelets by the spleen and introduced
splenectomy for treatment. This theory of excessive destruction of platelets in the
reticulo-endothelial system is supported by Wiseman, Doan and Wilson (1940).
An alternative method of producing a diminution of circulating blood platelets by
peripheral utilisation was suggested by Tidy (1926). He considered that the
primary defect lay in the capillary endothelium and that excessive numbers of
platelets were used in plugging vascular breaches.
The opposing theory of diminished platelet formation has many adherents since
Frank (1925) first suggested that the peripheral thrombocytopenia was due to
reduced platelet formation from megakaryocytes under the influence of the spleen.
This led Troland and Lee (1938) and many others to attempt to produce
thrombocytopenia in experimental animals, using splenic extracts. These experi-
ments produced very variable results. Indirect support for this theory of Frank
was adduced by Dameshek and Miller (1946), who demonstrated the presence of
a marked hyperplasia and maturation arrest of the megakaryocytes in the bone
marrow of untreated cases of chronic purpura. The restoration of the mega-
karyocytic pattern to normal following splenectomy led these authors to postulate
the presence of a splenic inhibitory substance which caused arrest of
megakaryocytic maturation.
The theory of peripheral platelet destruction has once again come into
prominence following the work of Evans et al. (1951), who put forward evidence
of an auto-immune mechanism in thrombocytopenic purpura similar to that
responsible for the erythrocytic destruction in acquired haemolytic anaemia. This
has been supported by Harrington and his co-workers (1951), who have
demonstrated an anti-platelet immune body in the serum of some patients
with thrombocytopenic purpura. Such a serum is capable of producing
114thrombocytopenia and clinical purpura when injected intravenously into normal
individuals.
From the diagnostic point of view idiopathic thrombocytopenic purpura is
regarded as that group of diseases characterised by a hemorrhagic diathesis
which manifests itself as ready bruising or free bleeding from mucous surfaces.
Haemorrhages may also occur into the skin producing petechiae, purpuric spots or
ecchymoses. The bleeding time is prolonged, the capillaries are unduly fragile
and, although the clotting time is normal, the clot fails to retract normally.
The platelet count is usually less than 100,000 per c.mm. but no evident cause
for the thrombocytopenia can be found. There may be slight anaemia but severe
anaemia is uncommon, and whatever its degree .it is always explicable by the
severity of the blood loss. Enlargement of the spleen is so uncommon in primary
thrombocytopenic purpura that it can be used as a clinical differential diagnostic
sign from purpura secondary to diseases of the reticulo-endothelial system.
Acute Idiopathic Thrombocytopenic Purpura.
Although all cases of idiopathic thrombocytopenic purpura satisfy the above
general diagnostic criteria, two distinct clinical varieties of this disease occur
(Hirsch and Dameshek, 1951). These differ in onset, clinical course, treatment
and prognosis. The first of these is acute thrombocytopenic purpura which is well
illustrated by the following case:-
Case 1.-A 41-year-old woman with no family history of bleeding had never suffered
from any tendency to haemorrhage during her lifetime and had not taken any drugs.
One day she slipped and fell, bruising her left leg. This bruise spread to produce an
extensive ecchymosis. Within four hours both her legs became covered with numerous
small blue spots and further large spontaneous bruises appeared. Severe epistaxis and
vaginal hamorrhage then developed and she was immediately admitted to hospital.
On examination there was generalised and extensive purpura of the skin of all four
limbs, chest, and abdomen. This was most marked around the ankles and was
associated with several large ecchymoses. Purpuric spots and blood-filled blisters were
present on the buccal mucosa. Bleeding occurred from the nose and the vagina and
catheter specimen of urine contained visible macroscopic blood.
The haemoglobin was 74% Haldane=10.9 gms./100 ml.; erythrocytes 3.74 x 106
per c.mm., leucocytes 3,100 per c.mm.; platelets 90,000 per c.mm.; bleeding time
grossly prolonged; clotting time normal; clot retraction poor. While in hospital the
epistaxis continued despite local hamostatic measures and further crops of purpuric
spots appeared. Two days after admission, when the platelet count had fallen further
to 52,000 per c.mm., the patient received one pint (570 mls.) of fresh compatible
whole blood. The bleeding immediately ceased from all mucous surfaces and the
purpuric rash subsided. Ten days after the onset the patient had recovered completely;
the platelets had risen to 280,000 per c.mm.; the bleeding time was normal and the
clot retraction good.
In this case the onset was sudden and dramatic in a patient with no previous
history of bleeding or ready bruising. Following an injury the patient noticed a
shower of purpuric spots on the legs which spread to involve the trunk and upper
limbs. These purpuric spots coalesced to form large ecchymoses. Bleeding occurred
from mucous surfaces with gross epistaxis and menorrhagia. Examination of the
blood showed a low platelet count which fell at one time to 52,000 per c.mm., and
115
Ka poorly retractile blood clot. The bleeding time was grossly prolonged. The
clinical manifestation lasted only a few days and the platelet count returned to
normal in ten days, the patient making a complete recovery. As acute thrombo-
cytopenic purpura is a self.limited disease with spontaneous and permanent
recovery usually within 4 weeks, treatment consists largely of expectancy. In
purpura there is always a danger of cerebral haemorrhage in patients over 40
years of age and consequently it may be necessary to control the haemorrhagic
episodes by transfusions of fresh (not stored) whole blood. Splenectomy, which
always carries an added risk if performed during an acute hawmorrhagic phase,
is not usually indicated.
Chronic Idiopathic Thrombocytopenic Purpura.
In chronic thrombocytopenic purpura the onset is gradual and the patient usually
gives a history of bleeding or ready bruising for many years with periods of
exacerbation and remission. Scattered petechie may appear from time to time
but true purpura may be entirely lacking. For this reason Hirsch and Dameshek
(1951) have suggested that the term purpura should be omitted from the
descriptive title of the disease which they suggest should be known as the
"chronic" thrombocytopenic state.
In this type of purpura the platelet count is only significantly reduced at periods
of relapse and in periods of remission may be normal. This also applies to the
other tests used in the diagnosis. On examination of the bone marrow the
presence of a megakaryocytic hyperplasia with no evidence of platelet production
is the usual but not invariable finding and it was this which led Dameshek and
Miller (1946) to postulate an inhibitory effect on the marrow by the spleen in this
disease.
Although splenectomy is usually immediately curative of the bleeding tendency,
as the normal course of the disease is subject to spontaneous fluctuations, the
treatment can only be regarded as successful if no further bleeding has occurred
for a period of six months after operation and if the platelet count remains normal
for the same period.
The following is an example of a case of chronic thrombocytopenia successfully
treated by splenectomy :
Case 2.-A 22-year-old chemist's assistant had always had severe and prolonged
menstrual bleeding since her menarche at 14, although her cycle was regular. She had
noticed a tendency to undue haemorrhage from tooth extractions and superficial wounds
but had not noticed spontaneous haemorrhage or 'spots' on the skin. There was no
family history of bleeding and the patient had not been exposed to any toxic drug.
When seen at the outpatient department her haemoglobin was 75% Haldane=11.1
gm./100 ml.; platelets 110,000 per c.mm.; bleeding time 6 mins.; coagulation time
normal; prothrombin 100%.
One month later she was admitted to hospital for investigation of her menorrhagia
and when in hospital she suddenly developed showers of petechia~on her chest and
limbs and bleeding from the gums. The spleen was not enlarged. The bleeding time was
18 mins.; coagulation time normal; platelets 46,000 per c.mm.; capillary fragility
increased. Examination of her bone marrow showed a marked megakaryocytic
hyperplasia with maturation arrest.
116Haemoglobin gm./100 ml.
Erythrocytes per c.mm.
Leucocytes per c.mm.
Platelets per c.mm. -
Bleeding Time/mins.
Capillary Fragility
TABLE 1. Six Months'
Pre-Splenectomy Post-Splenectomy
- - 10.4 ... 14.8
- - 3.5 ... 4.8
- - 11,000 ... 10,750
- - 46,000 ... 392,000
- - 18 ... 1' 30"
- - Increased ... Normal
This shows the haematological response to splenectomy in Case 2.
Splenectomy was carried out because of continued profuse vaginal bleeding un-
controlled by blood transfusion and associated with a further fall in the blood platelets.
Bleeding at operation was profuse but controllable by local application of topical
thrombin. On the fifth post-operative day signs of severe internal haemorrhage
appeared. This responded to transfusion of one pint (570 ml.) of fresh whole blood
and convalescence thereafter was uneventful. Since operation the patient has had no
further bleeding and has successfully undergone a plastic operation for removal of scars
from her face. When seen two years after her splenectomy the haemoglobin was
95% Haldane=14.1 g./100 ml.; platelets 270,000 per c.mm.; bleeding time 2 mins.;
capillary fragility normal and it would appear that splenectomy has produced marked
clinical and hamatological improvement.
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Showing the response of the bleeding time and platelet count to
splenectomy in Case 2.
Cortisone and A.C.T.H. in the Management of
Idiopathic Thrombocytopenic States.
The treatment of blood disorders with cortisone and A.C.T.H. by a large number
of workers has shown that the most encouraging results are obtained in acquired
haemolytic anaemia and chronic idiopathic thrombocytopenic purpura but these
117results are variable and often of short duration. In acute idiopathic throm-
bocvtopenic purpura these drugs do not appear to have any significant effect.
In chronic idiopathic thrombocytopenic purpura the effect of these hormones is
largely on the blood vessels, with an improvement in the capillary resistance and
a shortening of the bleeding time. An increase in the circulating blood platelets is
less consistently produced. Because of these temporary effects, the use of cortisone
and A.C.T.H. in the management of cases of thrombocytopenic purpura has
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The effect of cortisone and splenectomy on the bleeding time and
platelet count of Case 3 are recorded.
been restricted to the control of acute episodes of bleeding in chronic idiopathic
thrombocytopenic purpura and to the pre-operative preparation of patients for
splenectomy.
In many cases of idiopathic thrombocytopenic purpura the decision as to whether
the case is one of acute thrombocytopenic purpura or an acute exacerbation
in a chronic case may present serious difficulty. The following case is such an
example. This young girl presented with gross bleeding from mucous surfaces
and into the skin. She failed to respond to whole blood transfusions or significantly
to cortisone although this may have been due to the short period of its adminis-
tration. An emergency splenectomy was then carried out which produced a
complete clinical and haematological remission.
Case 3.-A 12-year-old schoolgirl had noticed bleeding from her gums for some
three weeks. This was followed by the appearance of a generalised, fine purpuric rash
over the whole body. She had numerous blood-filled blisters on her buccal mucosa and
lips. The hzemoglobin was 59% Haldane=8.7 g./100 ml.; leucocytes 8,000 per c.mm.;
platelets 50,000 per c.mm.; bleeding time 9 mins.; clotting time normal. A bone marrow
biopsy failed to show any significant megakaryocytic hyperplasia but the sample
118obtained was not entirely satisfactory. A few days later she had severe gastro-intestinal
haemorrhage with gross melana and was transfused with 6 pints (3420 ml.) of whole
blood. The gastro-intestinal haemorrhage occurred intermittently for a period of one
month; she developed vaginal bleeding and further crops of purpuric spots and required
more transfusions of fresh whole blood. She was started on a couise of cortisone when
her haemoglobin was 7.5 g./100 ml. =51% Haldane; platelet count 14,000 per c.mm.;
bleeding time more than 15 mins. and received 375 mgm. in 5 days without any
clinical response although there was a diminution in the bleeding time.
As the condition of the patient was critical it was decided to remove the spleen.
Accordingly pre-operative transfusion of fresh whole and stored blood was given to
a total of 10 pints (5700 ml.) and a splenectomy successfully cariied out. Two days
after the operation the platelet count began to rise and the bleeding time to return
to normal and she made an uneventful recovery which has been maintained for the
six months that the patient has remained under observation.
TABLE 2.
Six Months'
Pre-Splenectomy Post-Splenectomy
Haemoglobin g.1100 ml. - - 7.5 ... 13.0
Leucocytes per c.mm. - - 19,400 ... 9,650
Platelets per c.mm. - - 14,000 ... 240,000
Bleeding Time - - - 15 mins.+ ... 2 mins. 12"
Clot Retraction - - - Poor ... Good
Capillary Fragility - - Increased ... Normal
This shows the hcematological response to splenectomy in Case 3.
In another case of chronic idiopathic thrombocytopenic purpura in a boy of
3 years, cortisone given in a dose of 100 mgm. daily for ten days produced
considerable improvement in the bleeding time and platelet count but this effect
was only temporary. A second remission was induced with cortisone and
splenectomy successfully carried out.
Case 4.-A 3-year-old boy, with no family history of bleeding, first developed a
generalised purpuric rash in March, 1952. There was no haemorrhage from the mucous
membranes and no joint involvement. At that time the hWmoglobin was 88%
Haldane= 13.0 gm./100 ml.; leucocytes 12,000 per c.mm.; platelets 355,000 per c.mm.;
bleeding time 18 mins.; coagulation time normal. The purpura subsided but recurred
within two months when it was accompanied by ecchymoses and epistaxis. The
bleeding time was still prolonged although the platelet count was normal. The
hlemorrhagic diathesis responded to the transfusion of one half pint (285 ml.) of fresh
whole blood but this produced only temporary benefit. In July, 1952, because of a
recurrence of ecchymosis and epistaxis, the patient was readmitted to hospital. The
haemoglobin was 96% Haldane = 13.6 g. /100 ml.; leucocytes 11,900 per c.mm.; platelets
98,000 per c.mm.; bleeding time more than 15 mins. The bone marrow showed no
increase in the number of megakaryocytes or evidence of morphological abnormalities.
A course of cortisone consisting of 100 mgm. a day for ten days was then given and
the dose gradually reduced over a further ten days. This produced considerable
improvement in the clinical evidence of bleeding, caused a rise in the platelet count
in the peripheral blood and restored the bleeding time to normal. This beneficial
effect, however, only lasted 14 days when the platelet count fell to 50,000 per c.mm.,
the bleeding time again rose to more than 15 mins. and clinical purpura and ecchymoses
119reappeared. The boy was prepared for splenectomy by being given a short (5 day)
course of cortisone consisting of 175 mgm. daily which again restored the bleeding
time to normal. The post-operative course proceeded normally and no further episodes
of haemorrhage have occurred. The platelet count and bleeding time have been restored
to normal by the operation and have remained satisfactory for the six months that
the child has been observed.
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The effect of cortisone and splenectomy on the bleeding time and
platelet count of Case 4 are recorded.
SECONDARY THROMBOCYTOPENIC PURPURA.
In secondary thrombocytopenic purpura a decrease in the circulating blood
platelets may be produced as the result of the effect of haemototoxic drugs, and
among such drugs are the organic arsenicals. The appearance of purpura during
the therapy of syphilis with organic arsenicals may occur with dramatic sudden-
ness and subside spontaneously once the drug is withdrawn, as the following case
which was previously reported (Nelson, 1952) illustrates.
Case 5.-A 30-year-old woman with secondary sero-positive syphilis had been treated
with 3 mega units of penicillin followed over a period of somewhat less than a year
by 3 g. of bismuth metal, 0.86 g. of mapharsan and 7.2 g. of neoarsphenamine when
she suddenly noted the development of a black spotted 'rash' on her body and bleeding
from her gums. On admission to hospital an extensive petechial rash was present over
the face, arms and legs, being most extensive on the limbs. She was bleeding from
the gum margins and numerous blood-filled vesicles were seen in her mouth. She had
no haemoptysis, haematuria, hwematemesis or melaena. Her spleen was not palpable
and there were no ha~morrhages in the optic fundi. A capillary fragility test was
positive. The hoemoglobin was 12.0 g./100 ml. =81% Haldane; erythrocytes 4.30 x 106
per c.mm.; leucocytes 5,700 per c.mm.; platelets 54,000 per c.mm.; prothrombin 100%;
bleeding time greatly increased-25 mins.; clotting time normal. Examination of a
specimen of bone marrow obtained by needle biopsy showed a normal cellular marrow
with some reduction in the total number of megakaryocytes rather than a mega-
karyocytic hyperplasia with maturation arrest.
120TABLE 3.
During bleeding After spontaneous
episode recovery
Haemoglobin g./100 ml. - - 12.0 ... 17.0
Erythrocytes x 106 per c.mm. - 4.30 ... 5.95
Leucocytes per c.mm. - - 5,700 ... 5,700
Platelets per c.mm. - - 54,000 ... 240,000
Bleeding Time-mins. - - - 25 ... 3
Capillary Fragility - - - Increased ... Normal
The spontaneous haematological recovery following drug withdrawal
in Case 5 are recorded in this table.
On the day following admission the patient had a slight haematemesis and melwna
but the purpuric rash began to fade and she made a complete and spontaneous recovery.
This case illustrates the phenomenon of the reduction in the number of
circulating blood platelets with the development of purpura and spontaneous
mucosal haemorrhages as the result of exposure to a hwematotoxic drug. This toxic
action affected only one cell system in the marrow, viz., the megakaryocytes.
Both the granulocytic and erythrocytic precursors were unaffected. There was no
gross anwmia or leucopenia in the peripheral blood and, once exposure to the toxic
drug ceased, a rapid rise in the platelet Count occurred with spontaneous recovery.
In patients with syphilis, who are treated by organic arsenicals and who develop
thrombocytopenic purpura associated with peripheral pancytopenia, i.e.,
thrombocytopenia with severe anaemia and leukopenia, the marrow may be so
damaged that recovery may not occur even with strenuous treatment with
dimercaprol (Nelson, 1952).
The appearance of spontaneous bleeding or skin purpura may herald the
development of an aplastic or primary refractory anawmia. In certain cases the
haemorrhagic diathesis may so dominate the picture as to raise the possibility
of a diagnosis of primary idiopathic thrombocytopenic purpura. However, the
presence of a persistent anmemia not explicable by blood loss and a granulocytopenia
should arouse suspicion. The absence of primitive white cells in the peripheral
blood and examination of the bone marrow will exclude the hoemorrhagic onset of
a subleukaemic leuklemia. The bone marrow in chronic refractory anmmia may be
cellular or even hyperplastic and is not necessarily aplastic. It is for this reason
that the term 'primary refractory anaemia' is preferred for this group rather
than aplastic anmemia where the peripheral pancytopenia is associated with a grossly
acellular marrow.
Case 6.-A 22-year-old married woman had noticed, over a period of some ten
months, that her menstrual loss had become increasingly heavy. She became weak
and listless and was admitted to hospital, where she received a transfusion of eight
pints (4560 ml.) of whole blood. The heavy menstrual loss continued and she developed
frequent attacks of epistaxis which required her readmission to hospital. There
was no enlargement of spleen or lymph nodes. Her hemoglobin was 41% Haldane=
6.1 g./100 ml.; erythrocytes 1.84 x 106 per c.mm.; P.C.V.=18%; M.C.V.=100 cu;
leucocytes 2,530 per c.mm.; platelets 35,000 per c.mm.; bleeding time 20 mins.;
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Mclotting time normal; prothrombin concentration 100%; capillary fragility increased.
The marrow obtained by needle biopsy was examined on three occasions and showed
a cellular marrow with a normoblastic erythropoiesis. Megakaryocytes were in-
conspicuous in the marrow but showed normal morphology. Because of the peripheral
pancytopenia and cellular marrow a diagnosis of primary refractory anaemia was made.
However, as the haemorrhagic diathesis continued despite fresh blood transfusions a
splenectomy was carried out as a purely empirical measure in the hope of controlling
the haemorrhage. Since this operation her menstrual loss has been less heavy and
no further bleeding has occurred from other sites. However, her platelet count is still
low, her bleeding time intermittently prolonged and her anaemia and leucopenia still
present.
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This graph shows the haematological changes which resulted from
splenectomy in a case of primary refractory anaemia. The spontaneous
fluctuations in the bleeding time occurring independently of the
platelet count are particularly noticeable.
DISCUSSION.
Blood transfusion occupies pride of place in the treatment of purpura not only
as a general supportive measure to combat shock and blood loss but also as an
efficient haemostatic. As platelets disintegrate rapidly in contact with glass surfaces
freshly drawn whole blood is preferable to banked blood. The more recent
experiments carried out on blood withdrawn through silicone-coated tubing and
stored in silicone-coated glassware have shown that this reduces greatly the rate
of platelet distintegration. This technique offers the hope of transfusing a more
platelet.rich blood in the future. Indeed the therapeutic value of this form of
treatment in thrombocytopenia and thrombopathia has already been reported (van
Creveld et al. 1953), and in our hands has been most effective in controlling
haemorrhage and raising the platelet count..
122If the haemorrhage is due to a platelet deficiency produced by the effect of
haematotoxic drugs acting on the megakaryocytes in the bone marrow, the
outcome of drug withdrawal or elimination will largely depend on the degree
and extent of damage to the immature cells in the marrow. When the mega-
karyocytes only are damaged, a pure thrombocytopenic purpura is produced
without severe anaemia or leucopenia. Such cases have a prompt and spontaneous
clinical and ha:matological recovery once the toxic drug is removed. When the
marrow damage is extensive so that the megakaryocytes, the primitive granulocytes
and the red cell precursors are all found to be affected, the hzemorrhagic diathesis
is associated with severe anaemia and granulocytopenia and recovery is unlikely
(Nelson, 1952). The prognosis in cases of purpura due to hematotoxic drugs
therefore depends on the damage to the whole haemopoietic system and the
outcome can be inferred, to some extent, from an examination of the peripheral
blood and bone marrow.
Purpura may complicate a number of diseases affecting the hawmopoietic system,
where it is often a terminal manifestation. However, in some cases of refractory
or aplastic an;emia the presence of purpura may be the presenting and pre-
dominating sign (Case 6). In the absence of any sure knowledge as to the atiology
of primary refractory anamia and the lack of response to any of the known
haemopoietic drugs these cases are usually maintained with blood transfusions.
Although splenectomy has been carried out in some cases of primary refractory
anaemia, the results have not been encouraging. It is only in cases with an active
cellular marrow that splenectomy is likely to be followed by beneficial results.
Here it is postulated that the spleen is exerting some inhibitory effect on the
marrow which is relieved by splenectomy. In one case of primary refractory
anemia presenting as a haemorrhagic diathesis the effect of removal of the spleen
was to produce immediate cessation of the bleeding tendency with a temporary
restoration of the bleeding time which has since shown frequent remissions and
relapses. The low platelet, erythrocyte and leucocyte counts have persisted but
the haemoglobin has, for a limited period, been fairly satisfactorily maintained so
that the patient has only required a blood transfusion once in the twelve months
since her operation. This case also clearly demonstrated the lack of correlation
which can exist between the bleeding time and the platelet count. In purpura it
has been shown that the bleeding time is paralleled by the capillary fragility but
not by the platelet count, and that both bleeding time and capillary fragility are
increased during periods of active bleeding with associated skin purpura. The
only tests which can be correlated with any degree of accuracy with the platelet
count are the clot retraction and rate of prothrombin consumption. This is one of
the facts which suggests that the low platelet count is not entirely responsible for
the haemorrhagic manifestations which may have an underlying vascular origin.
Acute idiopathic thrombocytopenic purpura has such a dramatic presentation
and bleeding may be so profuse that the unwary may be trapped into carrying out
an emergency splenectomy which carries an undue risk, if carried out under such
123circumstances. The management of these cases resolves itself into the control of
the acute bleeding episode and the practice of a policy of watchful expectancy to
see if spontaneous recovery occurs. Control of this bleeding can most readily be
achieved by the transfusion of fresh (not stored) whole blood. The value of
cortisone or A.C.T.H. in acute thrombocytopenic purpura is dubious, as some
workers have been unable to detect any clinical or haematological difference in the
course of patients treated with A.C.T.H. and cortisone and other patients left
untreated. Because splenectomy is followed by clinical improvement in the bleeding
tendency and a rise in the platelet count, the decision to carry out this operation
in a case of acute thrombocytopenic purpura may be forced by the developments
in the individual case which is not showing signs of spontaneous recovery. Under
these circumstances the presence of uncontrollable hamorrhage threatening life
or of severe bleeding, particularly in patients over 40 years of age where there
is the ever-present risk of cerebral haemorrhage, are two possible indications for
splenectomy.
Splenectomy in chronic thrombocytopenic purpura is the elective form of
treatment and is followed by permanent recovery in a high percentage of cases.
The decision here is the timing of the operation, for the risk is less if the operation
is carried out once the acute hkemorrhagic episode has subsided. Here a pre-
operative course of cortisone or A.C.T.H. is most useful in helping to restore
the bleeding time to normal and to control the haemorrhagic manifestations. This
effect is maximal about the seventh day of administration and consequently the
operation can be performed at a time when the risk of both operative and post-
operative haemorrhage is reduced to a minimum.
The appropriate treatment of an individual case of idiopathic thrombocytopenic
purpura may present a problem of considerable difficulty to the physician or
surgeon. The major difficulty is to know whether the case is one of acute
thrombocytopenic purpura or an acute episode in a chronic case. The most helpful
points are (1) In chronic purpura there is a previous history of bleeding or ready
bruising which is not obtained in acute purpura. (2) The clinical manifestations in
acute purpura are those of severe bleeding with widespread gross purpura and
ecchymoses, while in an acute exacerbation of chronic purpura the skin manifes-
tations usually consist of petechiaw, localised to the legs rather than generalised
purpura. (3) The haematological changes in acute purpura are more marked than
in chronic purpura.
The differential diagnosis is important and not merely academic. It is the
differential diagnosis between an acute self-limited disease in which the danger
from splenectomy is great and a chronic persistent disorder in which, at the
moment, splenectomy carries the only hope of complete cure. It is a problem which
taxes to the full the judgement and skill of the physician.
SUMMARY.
Idiopathic thrombocytopenic purpura occurs in two clinical forms.
Acute idiopathic thrombocytopenic purpura is a self-limited disease in which
12Mcontrol of severe haemorrhage can be achieved by the transfusion of fresh whole
blood while awaiting spontaneous recovery.
Chronic idiopathic thrombocytopenic purpura is a disease liable to fluctuating
remissions and relapses. In relapse the acute bleeding episode may be controlled
by transfusion of fresh whole blood or cortisone therapy. If the bleeding is
uncontrollable, threatening vital structures or is persistently recurrent, splenectomy
is indicated.
In secondary thrombocytopenic purpura due to hematotoxic drugs, recovery
is prompt following withdrawal of the drug. If the haematotoxic drug has
produced severe marrow damage with peripheral pancytopenia the prognosis is
poor.
In one case of primary refractory anzemia with a secondary thrombocytopenic
purpura splenectomy has relieved the bleeding tendency without affecting
significantly the underlying disease process.
It gives me great pleasure to acknowledge my indebtedness to the many physicians who
afforded me the opportunity of seeing cases which were under their care and to Mr. A. Lamont
for his technical assistance.
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